Wagging the dog-moving closer to features defined by basic scientists, the protection of prodromal transient ischaemic attacks reveals itself

European Journal of Neurology

Volumn 15, Issue 8, 2008, Pages 755-756

  McLaughlin, B A ^a   Kirshner, H ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; EDITORIAL; HUMAN; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; PRIORITY JOURNAL; RISK FACTOR; SCIENTIST; TRANSIENT ISCHEMIC ATTACK; NOTE; PATHOPHYSIOLOGY; STROKE;

HUMANS; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC PRECONDITIONING; STROKE;

EID: 54549111181     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02189.x     Document Type: Editorial

References (12)

1. Pasupathy S, Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. European Journal of Vascular and Endovascular Surgery 2005; 29: 106.
2. Castillo J, Moro MA, Blanco M, et al. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Annals Of Neurology 2003; 54: 811-819.
3. Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA study. Stroke 2004; 35: 2680-2682.
4. Fu Y, Sun JL, Ma JF, et al. The neuroprotection of prodromal transient ischemic attack on cerebral infarction. European Journal of Neurology 2008; 15: 797-801.
5. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proceedings of the National Academy of Sciences ofthe United States ofAmerica 1995; 92: 4666-4670.
6. Barone FC. Endogenous brain protection-models, gene expression, and mechanisms. Stroke Genomics: Methods And Reviews 2004; 104: 105-184.
7. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neu-roprotective effect? Neurology 2000; 54: 2089-2094.
8. Schaller B, Graf R. Cerebral ischemic preconditioning -an experimental phenomenon or a clinical importantentity of stroke prevention?. Journal OfNeurology 2002; 249: 1503-1511.
9. McLaughlin BA, Hartnett KA, Erhardt JA, et al. Caspase 3 activation is essential for neuroprotection in ischemicpreconditioning. Proceedings ofthe National Academy ofSciences of the United States of America 2003; 100: 715-720.
10. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis ofTIA. The Journal ofthe American Medical Association 2000; 284: 2901-2906.
11. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. The Lancet 2007; 370: 1432.
12. Klijn CJM, Hankey GJ. Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European stroke initiative. The Lancet Neurology 2003; 2: 698.